Test Price
2,800 AED✅ Home Collection Available
IGBP1 Gene Genetic Test for Corpus Callosum Agenesis Syndrome in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 accredited NGS workflow for IGBP1 gene variants.
- Collection Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection daily from 8 AM to 11 PM, staffed by DHA-licensed phlebotomists.
- Post-Test Support: Complimentary telephonic interpretation by a Consultant Medical Geneticist (DHA ID: 9294403) following result delivery.
- Insurance Facilitation: Direct billing pre-verification and approval assistance available via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next-generation sequencing (NGS) assay provides complete coverage of the IGBP1 gene, detecting single nucleotide variants, small insertions/deletions, and copy number alterations responsible for syndromic agenesis of the corpus callosum with intellectual disability, ocular coloboma, and micrognathia. The enhanced resolution of NGS over traditional Sanger sequencing enables definitive molecular diagnosis and informs targeted clinical management for patients in the UAE.
| Feature | DNA Labs UAE NGS Test | Single Gene Sanger Alternative |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) | Sanger Sequencing |
| Gene Coverage | Full gene including deep intronic regions | Selected exons only |
| Turnaround Time | 3 to 4 Weeks | 6 to 8 Weeks |
| Diagnostic Sensitivity | >99.9% | ~95% |
| Sample Types | Blood, DNA FTA Card, Extracted DNA | Blood only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403), advises: "While this NGS assay delivers highly accurate molecular data for IGBP1-related disorders, the results must always be integrated with a comprehensive clinical evaluation, brain MRI, and ophthalmologic examination. I strongly recommend multidisciplinary involvement from a paediatric neurologist, ophthalmologist, and genetic counsellor to formulate a holistic care plan. Genetic findings alone cannot replace thorough clinical judgment."
Patient Advisory & Medication Safety
Critical Safety Information
Do not discontinue or alter any prescribed medication without consulting your treating physician. Laboratory results should complement, not replace, ongoing clinical supervision.
- Exclusion Criteria: Active systemic infection; inability to provide valid informed consent; minors under 18 years without parental or guardian consent.
- Emergency Red Flags — Seek Immediate Care: Acute onset of seizures, sudden developmental regression, rapid vision loss, or signs of increased intracranial pressure (persistent vomiting, lethargy, altered consciousness). Do not delay emergency treatment for test scheduling.
Patient FAQ & Clinical Guidance
1. What exactly does the IGBP1 gene test diagnose?
This test identifies pathogenic variants in the IGBP1 gene associated with corpus callosum agenesis, intellectual disability, ocular coloboma, and micrognathia. It provides a confirmed molecular diagnosis, enabling accurate prognosis, family counselling, and targeted management planning within the UAE healthcare system.
2. How is the sample collected and what is the turnaround time?
A blood sample or DNA FTA card is collected at your residence by a DHA-licensed phlebotomist using a temperature-controlled cold-chain logistics system. Alternatively, you may visit our Dubai Healthcare City facility for collection. Results are delivered within 3 to 4 weeks via our ISO 9001:2015 accredited laboratory.
3. Is the test covered by insurance and what post-test support is provided?
We offer direct billing verification and pre-approval assistance through WhatsApp at +971 54 548 8731. After results are released, you will receive a complimentary telephonic consultation with our Consultant Medical Geneticist to clarify findings, discuss inheritance patterns, and coordinate specialist referrals.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
All genetic data generated by this test is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE operates under DHA Facility License No. 1143 and maintains ISO 9001:2015 certification for quality management.
Clinical & Logistical Metadata
| Test Name | IGBP1 Gene Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Blood, DNA FTA Card, Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | Q04.0, Q87.8 |
| LOINC Code | 81304-9 |
| DHA Facility License & Laboratory Address | Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians